Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis.
The local and systemic release of thromboxane A2, prostaglandin I2, leukotriene B4 (LTB4), tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and interleukin-8 (IL-8) were studied before and after operation in 29 patients with acute and 22 with chronic posttraumatic osteomyelitis. Twenty patients without osteomyelitis, who underwent operations for fractures of the lower extremities, served as controls. Blood and tissue samples from the osteomyelitic and control groups were collected under defined conditions and mediators were determined by radioimmunoassay (thromboxane B2, 6-keto-prostaglandin F1 alpha, LTB4) or by enzyme-linked immunosorbent assay (TNF-alpha, IL-1 beta, and IL-8). In addition, common parameters (leukocyte count, C-reactive protein, temperature) were measured. The best correlation with acute disease activity was given by TNF-alpha, IL-6, IL-8, and LTB4. Plasma levels of these mediators in acute osteomyelitis were significantly increased compared to chronic osteomyelitis and to controls, respectively. Tissue samples from osteomyelitic focus showed significantly increased levels for IL-8, IL-6, TNF-alpha, IL-1 beta, and LTB4 in acute osteomyelitis, whereas the values for TxB2 and 6-keto-prostaglandin F1 alpha were only slightly increased compared to the chronic osteomyelitis group. This study describes the local and systemic liberation of various mediators in acute and chronic posttraumatic osteomyelitis in detail for the first time and provides data for pre- and postoperative monitoring of disease activity and demonstrates new pathogenetic and therapeutic aspects of bone modulation in osteomyelitis.
Klosterhalfen
B
B
Institute of Pathology, Technical University of Aachen, Germany.
Peters
K M
KM
Tons
C
C
Hauptmann
S
S
Klein
C L
CL
Kirkpatrick
C J
CJ
D000208:Acute Disease; D000328:Adult; D016022:Case-Control Studies; D002908:Chronic Disease; D016207:Cytokines / Q000097:blood*; D015777:Eicosanoids / Q000097:blood*; D011464:Epoprostenol / Q000097:blood; D005260:Female; D050723:Fractures, Bone / Q000150:complications; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D016209:Interleukin-8 / Q000097:blood; D007975:Leukotriene B4 / Q000097:blood; D008297:Male; D008875:Middle Aged; D010019:Osteomyelitis / Q000097:blood* / Q000209:etiology / Q000601:surgery; D013928:Thromboxane A2 / Q000097:blood
D016207:Cytokines; D015777:Eicosanoids; D015850:Interleukin-6; D016209:Interleukin-8; D007975:Leukotriene B4; D013928:Thromboxane A2; D011464:Epoprostenol